Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000473748 | SCV000554967 | likely benign | Neurofibromatosis, type 1 | 2024-08-28 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821312 | SCV002070808 | uncertain significance | not specified | 2019-05-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002365680 | SCV002658567 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2020-05-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |